Business
Presentation of Virtual Tumou
Presentation of Virtual Tumou.
About this update from Physiomics Plc
[{"type":"text","content":"\n RNS Number : 2124W Physiomics PLC 16 November 2010 \n \n\nPhysiomics plc\n(\"Physiomics\" or \"the Company\")\n \nPhysiomics to present the Virtual Tumour platform at the 2010 EORTC-NCI-AACR symposium on \"Molecular targets and Cancer Therapeutics\" \n \nPhysiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the EORTC-NCI-AACR symposium on \"Molecular Targets and Cancer Therapeutics\", taking place at the Estrel Hotel and Convention Centre, Berlin, Germany on 16-19 November 2010. Dr Eric Fernandez, Project Leader at Physiomics, will present the latest development of our Virtual Tumour platform.\n \n \nThe Virtual Tumour is a computer model that integrates pharmacokinetic and pharmacodynamic data in order to simulate the effect of anti-cancer drugs on growing tumours. Once calibrated with the data generated during research and development of a drug, this predictive tool can be used to rationally design and optimise schedules for drug combination. Coupled to our High Performance Computer, the model can simulate thousands of possible drug combination schedules that would be effectively impossible to investigate experimentally, and allow prioritisation of the most effective drug combinations.\n \nThe abstract (\"The Virtual Tumour, a predictive simulation platform to optimize anti-cancer drug scheduling and combination\", No 565) will be presented in the \"Bioinformatics\" poster session, scheduled 08:00 PM - 1:00 PM, 19 November 2010.\n \nMore information about the conference may be found at:\nwww.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/page.aspx/1386\n \nDr Christophe Chassagnole, COO of Physiomics, said\n \n \n\"We are pleased to present this current development to the major oncology summit in Europe, which gathers the major players in the oncology field. We show here a validation study of our technology and we expect this will trigger interest from the conference attendees.\"\n \n \n \nEnquiries:\n \nPhysiomics plc ...